Serum CA-125 tumor marker in endometrial adenocarcinoma

One hundred and seventy-four patients, mean age 61.23 +/- 9.41 years old, with irregular perimenopausal haemorrhage were included in the study. Fractional curettage was performed in all patients. When the pathohistologic findings were adenocarcinoma the concentration of CA-125 tumor marker was determined. Hysterectomy with bilateral salpingo-oophorectomy was determined. In 142 cases carcinoma was restricted to the uterus and in 32 patients extrauterine metastatic disease was found. In the former group CA-125 was positive in 130 patients with a mean value of 64.12 +/- 22.41 U/ml serum. In the latter group the cancer antigen was positive in 29 patients with a mean value of 244.82 +/- 68.11 U/ml. High production is associated with increased metastatic potential.

CA-125; Endometrial cancer

[1] Bast R. C. et al.: "A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer". N. Engl J. Med., 1983, 309, 883.

[2] Niloff J.M., Klug T. L., Schaetzl E., Zurawski V. R., Knapp R. C., Bast R. C.: "Elevation of serum CA-125 in carcinomas of the fa]lopian tube, endometrium, and endocervix". Am. J. Obstet. Gynecol., 1984, 15, 1057.

[3] Sood A. K., Buller R. E., Burger R. A., Dawson J. D., Sorosky J I., Berman M.: "Value of preoperative Ca 125 level in the management of uterine cancer and prediction of clinical outcome" Obstet. Gynecol., 1997, 90 (3), 441.

[4] Kurihara T., Mizunuma H., Obara M., Andoh K., Ibuki Y., Nishmura T.: "Determination of a normal level serum CA-125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma". Gynecol. Oneal., 1998, 69 (3), 192.

[5] Dotters D. J.: "Preoperative CA 125 in endometrial cancer: is it useful?". Am. J. Obstet. Gynecol., 2000, 182 (6), 1328.

[6] Koper N. P., Massuger L. F., Thomas C. M., Kiemeney L. A., Verbeek A. L.: "Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy". Anticancer Research., 1998, 18 (3B), 1897.

[7] Kukura V., Zaninovic I., Hrdina B.: "Concentrations of CA-125 tumor marker in endometrial carcionoma". Gynecol. Oncol., 1990, 37, 388.

[8] Patsner B.: "Endometrial cancer in women 45 years of age or younger". Eur. J. Gynecol. Oncol., 2000, 21 (3), 249.

[9] Yabushita H., Shimazu M., Yamada H., Sawaguchi K., Noguchi M., Nakanishi M., Kawai M.: "Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer". Gynecol. Oncol., 2001, 80(2), 139.

[10] Fujimura H., Kikkiawa F., Oguchi H., Nakashima N., Mizutani S. "Adjuvant chemotherapy including cisplatin in endometrial carci­noma". Gynecol. Obstet. Invest., 2000, 50 (2), 127.

[11] Lo S.S., Khoo U.S., Cheng D. K., Ng T. Y., Wong L. C., Ngan H. Y.: "Role of serial tumor markers in the surveillance for recur­rence in endometrial cancer". Cancer Detect. Prevent., 1999, 23 (5), 397.

[12] Cherchi P. L., Dessole S., Ruiu G. A., Ambrosini G., Farina M., Capobianco G., Ambrosini A.: "The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma". Eur. J. Gynaecol. Oneal., 1999, 20 (4), 315.

[13] Alcazar J. L., Jurado M., Lopez-Garcia G.: "Comparative study of transvaginal ultrasonography and CA 125 in the preoperative eva­luation of myometral invasion in endometrial carcinoma". Ultra­sound Obstet. Gynecol., 1999, 14 (3), 210.

[14] Hardesty L. A., Sumkin J. H., Hakim C., Johns C., Nath M.: "The ability of helical CT to preoperatively stage endometrial care卜 noma". A. J. R. Am. J. Roentgen., 2001, 176 (3), 603.

[15] Marchetti M., Litta P., Lanza P., Lauri F., Pozzan C.:'The role of hysteroscopiy in early diagnosis of endometrial cancer". Eur. J. Gynaecol. Oncol., 2002, 23 (2), 151.